A far shorter, simpler, and less toxic treatment protocol for patients with triple-negative breast cancer produced outcomes ...

Medically reviewed by Aleesha Grier, PsyD A diagnosis of metastatic breast cancer can be overwhelming, and one of the many ...

A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost ...

The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the ...

After living with metastatic breast cancer for 11 years, I reflect on my journey and plan to embrace the coming year with ...

The University of Iowa study is analyzing the period between breast cancer diagnosis and treatment, when many patients feel ...

Katrina Cooke and Ashley Dostefano share their personal journeys, reflecting on the challenges they faced, the victories they ...

Some oncologists suggest that, for certain early cancers not at risk of spreading, the term “cancer” should be avoided.

Among patients with advanced PIK3CA-mutated, HR-positive/HER2-negative breast cancer, Itovebi-based treatment generated positive overall survival results.

A Peter Mac-led international clinical trial has shown adding an immunotherapy drug to the chemotherapy that patients receive ...

The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...

Jan. 22, 2025 — Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment typically involves surgery and follow-up hormone ...